Medical information (MI) departments occupy an unusual space in the pharmaceutical ecosystem. They sit at the boundary between clinical communication and regulatory compliance, fielding product queries from healthcare professionals and patients while simultaneously feeding into pharmacovigilance and product quality complaint workflows. That dual role makes the MI function a genuinely high-value audit target, and one that many auditors underestimate.

Here is what a rigorous audit of the MI function should cover, and why each area matters more than most compliance checklists acknowledge.

---

The Database: More Than Just Storage

The MI database is the operational backbone of the function. An audit should begin here, not because it is the most interesting area, but because weaknesses in the database tend to cascade into everything else.

Validation status is the first question. Has the database been validated to the degree required for its intended use? This is not a checkbox exercise. Auditors should ask for validation documentation and test it against actual system functionality, particularly if there have been updates or configuration changes since original validation.

Data integrity deserves equal scrutiny. Can the system prevent or detect unauthorized amendments to records? Are audit trails complete and protected? If the MI database is integrated with the safety database or the product quality complaint system, that integration itself warrants review. Poor integration architecture is a common source of data gaps, duplication, and missed follow-up. Any history of data migration adds another layer of risk. Data migration projects frequently introduce record-level errors that never get cleaned up. If a migration occurred, auditors should sample records across the pre and post-migration periods and look for inconsistencies.

One scenario worth probing specifically: what happens when the sponsor mandates use of their own database rather than the service provider’s platform? This has SOPs implications that often go unaddressed. Who owns the records? Where does the validated instance reside? What happens to the data if the contract terminates?

---

Call-Handling Software: Functional and Compliant?

The call-handling platform is where the MI interaction begins. Auditors should verify that the software is fit for purpose in the regulatory sense, not just operationally adequate. Key questions include whether call recording is implemented consistently, whether recordings are stored securely with appropriate retention controls, and whether the system supports the documentation requirements for adverse events (AEs) and product quality complaints (PQCs) captured during calls.

Testing and quality check processes should be formally defined. What does the organization do before onboarding a new agent? How are calls reviewed post-interaction? Is there a structured quality scoring framework, or is review left to individual team leader discretion?

---

Sub-contracting and Service Provider Contracts

If any part of the MI function is outsourced, the audit scope must extend to the service provider. The contract should clearly define the services covered, performance standards, and the division of responsibility for AE and PQC reporting. Auditors often find that contracts are detailed on service levels and pricing but vague on regulatory responsibilities. This is a gap with real consequences.

The sponsor’s oversight obligation does not transfer with the contract. If the provider receives an AE report and fails to pass it on within the required timeframe, the regulatory responsibility lands squarely on the sponsor. The audit should verify that oversight mechanisms are active, not theoretical. This means documented oversight visits, KPI reviews, and deviation tracking, not just a clause in the contract.

---

Training: AE and PQC Recognition

This is an area where the gap between policy and practice is routinely wider than organizations expect. MI staff need to recognize a potential adverse event or product quality complaint embedded in what the caller presents as a routine product query. That recognition depends on training that is current, role-specific, and regularly tested.

Auditors should review training records for completeness, but more importantly, they should test comprehension. A brief scenario-based assessment during the audit visit will reveal whether agents understand the threshold for AE reporting far better than a training attendance log ever will. Training curricula should be updated whenever the product labeling changes or a new safety signal emerges. If the training has not been refreshed in 12 to 18 months, that is a finding worth noting.

---

Source Data Retention

Two categories of source data require attention here. The first is hard copy documentation, query records, written responses, and reference materials. The second is recorded calls. Both must be retained for periods consistent with regulatory requirements and company policy.

Auditors should verify that retention schedules are documented, that the physical or electronic storage is secure and accessible, and that destruction of records at end-of-retention follows a formal process. It is not unusual to find that call recordings are retained, but there is no formal procedure governing who can access them, under what circumstances, and how that access is logged.

---

FAQs, Product Information, and Escalation

The FAQ document set represents the organization’s curated knowledge base for responding to product queries. Auditors should assess whether FAQs are subject to version control, whether they are reviewed at defined intervals, and whether they are aligned with the current approved labeling.

The escalation process deserves specific attention. What happens when an MI query cannot be answered using available resources? Is there a documented escalation pathway to medical affairs or regulatory? Are escalation timelines defined and monitored? In practice, escalation processes are frequently documented at the SOP level but poorly observed in day-to-day operations.

---

Out-of-Office Coverage and Business Continuity

Coverage gaps are a persistent vulnerability in MI operations. Auditors should verify that out-of-office coverage is formal and documented, not reliant on informal agreements between colleagues. Who covers during weekends? During public holidays? During planned absence? During unplanned absence?

Business Continuity Planning (BCP) and Disaster Recovery (DR) should be reviewed as part of this area. If the primary call-handling system goes down, what is the fallback? If the service provider’s operations are disrupted, what is the sponsor’s contingency? BCP documents that have never been tested should be treated as aspirational rather than operational.

---

Labeling and Q&A Currency

MI staff must have access to the current version of approved labeling at all times. This sounds elementary, but labeling management is a recurring audit finding, particularly in organizations that manage multiple products across multiple markets. The audit should verify that there is a defined process for distributing updated labeling to MI teams and that staff can demonstrate they are working from the current version.

The same principle applies to Q&A documents. Superseded Q&As should be archived, not left in circulation.

---

Reconciliation

Reconciliation between the MI database and the safety database is a regulatory requirement in many jurisdictions and a best practice everywhere. Auditors should verify that reconciliation is performed at defined intervals, that the reconciliation process is documented, that discrepancies are investigated and resolved, and that reconciliation records are maintained.

Reconciliation findings provide a useful proxy for assessing the overall health of the AE intake process within the MI function.

---

Translation Methodology

If the MI service covers markets where queries may be received in multiple languages, the audit should address how translation is handled. Is there a defined list of supported languages in the contract? What happens when a caller contacts the service in a language not listed? Is machine translation used, and if so, under what controls? Translation errors in a medical context carry obvious patient safety implications, and the methodology should be robust and documented accordingly.

---

Data Privacy

Personal data flows through the MI function at every interaction. The caller’s identity, medical history, and contact details are all collected in the process of handling a query. Auditors should verify that the MI function operates within the applicable data privacy framework, whether that is GDPR, India’s Digital Personal Data Protection Act, or another jurisdiction’s requirements.

Consent management, data minimization, cross-border data transfer controls, and the handling of data subject access requests all fall within scope. Privacy impact assessments, where required, should be documented and current.

---

Job Descriptions and Role Clarity

This is one of the more neglected areas in MI audits. Job descriptions (JDs) should accurately reflect the activities performed by MI staff, including regulatory reporting obligations. Version history should be maintained. JDs should be signed off by an appropriate authority and reviewed when the role changes materially.

Blank fields in JDs, absence of version control, or JDs that have not been reviewed since an employee joined years ago are all indicators of a function that treats documentation as a formality rather than a compliance tool.

---

Cross-Country and Cross-Product Queries

What happens when a healthcare professional contacts the MI service about a product that is approved in a different country, or with a different indication from the one covered by the local marketing authorisation? This scenario is more common than it appears, and the handling is frequently undefined at the SOP level.

Auditors should probe this area with a specific scenario. The response reveals how well the function has thought through its operational boundaries and how effectively it communicates those boundaries to callers.

---

Oversight, Internal Audit, and the PSMF

The MI function should be subject to internal oversight, including performance monitoring, periodic internal reviews, and external audits at appropriate intervals. Findings from those reviews should be tracked through to resolution.

The connection between MI and the Pharmacovigilance System Master File (PSMF) requires explicit attention. Decentralized MI operations, where the function is distributed across sites or outsourced to a CRO, create documentation obligations under the PSMF. Auditors should verify that the PSMF accurately reflects the MI function’s structure, governance, and outsourcing arrangements.

---

Should Medical Inquiries Be Covered in Pharmacovigilance Agreements?

This is a question that generates more debate than it should. The practical answer is: yes, to the extent that the MI function is a source of safety data. Pharmacovigilance Agreements (PVAs) should address the obligations of parties who receive and transmit safety information regardless of the channel through which that information arrives. An MI query that contains a spontaneous AE report is a safety-relevant interaction. If the PVA does not acknowledge the MI channel, there is a structural gap in the safety information flow that the agreement is supposed to govern.

Auditors should assess this connection explicitly and flag any PVA that treats MI as entirely outside its scope.

---

Medical information auditing is one of those areas where the audit findings tend to cluster around implementation rather than policy. The SOPs usually exist. The challenge is almost always in the gap between what the SOP says and what actually happens on a given Tuesday afternoon when a bilingual caller rings in, the primary system is slow, and the responsible person is on leave. A good MI audit puts pressure on exactly that gap, and closes it before a regulator does.